The race for LA mayor has two candidates from the Democratic Socialists of America (DSA), including City Council member Nithya Raman. It is worth a look at the DSA’s political platform. The first item ...

A specter is haunting New York politics – the specter of the Democratic Socialists of America. Over the past 10 years, the socialist organization has had its ups and downs, but recently it has been on ...

Researchers at MIT's CSAIL published a design for Recursive Language Models (RLM), a technique for improving LLM performance on long-context tasks. RLMs use a programming environment to recursively ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

New York City’s chapter of the Democratic Socialists of America (DSA) is organizing a large-scale effort to mobilize thousands of activists to respond to anticipated federal immigration enforcement ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Mayor-elect Zohran Mamdani argued that an endorsement of a left-leaning ally, Chi Ossé, would hurt his efforts to secure mainstream Democratic support for his proposals. By Benjamin Oreskes Of all the ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...